M. Leyton et al., Depressive relapse following acute tryptophan depletion in patients with major depressive disorder, J PSYCHOPH, 14(3), 2000, pp. 284-287
Acute tryptophan depletion (ATD) lowers serotonin synthesis and elicits dep
ressive symptoms in some, though not all, remitted patients with major depr
essive disorder (MDD). In the present study, eight medication-free remitted
patients with MDD, seasonal pattern, were tested twice, once following the
ingestion of a tryptophan-containing mixture, once following ATD, ATD sign
ificantly increased Hamilton depression scores (p < 0.001). Four of the pat
ients had a family history of psychiatric disorders: substance abuse (n = 4
), mood disorders (n = 3) or Cluster B personality disorders (n = 3). The m
ood-lowering response to ATD was significantly greater in those patients wi
th, than without, affected relatives (p < 0.001). These preliminary finding
s (1) support the hypothesis that depressed states are related to disturbed
serotonin neurotransmission and (2) suggest that depressive symptoms follo
wing ATD might identify a subgroup of patients at high genetic risk for dis
orders associated with affective lability and dysregulated impulse-control,
conditions thought to be related to low serotonin neurotransmission.